T1 Biomarker 470 478 h-iNSCTE
T2 Condition 30 34 NSCs
T3 Level 866 885 human GBM spheroids
T4 Level 639 644 human
T5 Biomarker 767 777 Time-lapse
T6 Level 232 250  human fibroblasts
T7 Condition 1702 1708 cancer
T8 Condition 30 33 NSC
T9 Biomarker 1197 1222 h-iNSCTE thymidine kinase
T10 Protein 1059 1064 TRAIL
T11 Level 1292 1307 patient-derived
T12 Biomarker 667 675 h-iNSCTE
T13 Protein 1259 1270 h-iNSCTE–TK
T14 Level 835 850 human GBM cells
T15 Biomarker 1223 1241 ganciclovir enzyme
T16 Biomarker 806 814 h-iNSCTE
T17 Biomarker 1197 1205 h-iNSCTE
T18 Condition 1102 1112 xenografts
T19 Disease 525 544 nonsurgical disease
T20 Condition 1408 1411 NSC
T21 Level 1601 1605  TD 
T22 Condition 289 293 NSCs
T23 Protein 922 927 CXCR4
T24 Condition 1392 1395 NSC
T25 Level 1292 1311 patient-derived GBM
T26 Protein 1660 1672 tumor-homing
T27 Condition 103 106 NSC
T28 Level 233 238 human
T29 Condition 298 301 NSC
T30 Condition 670 673 NSC
T31 Condition 1200 1203 NSC
T32 Condition 1262 1265 NSC
T33 Level 835 840 human
T34 Level 1092 1097 human
T35 Condition 1000 1057 tumor necrosis factor–α–related apoptosis-inducing ligand
T36 Condition 289 292 NSC
T37 Level 482 497 patient-derived
T38 Level 616 620  TD 
T39 Biomarker 295 303 h-iNSCTE
T40 Biomarker 956 964 h-iNSCTE
T41 Condition 473 476 NSC
T42 Condition 1627 1630 NSC
T43 Condition 1312 1322 xenografts
T44 Biomarker 1242 1257 prodrug therapy
T45 Condition 809 812 NSC
T46 Level 612 661 SOX2 TD strategy converted human skin fibroblasts
T47 Protein 409 421 tumor-homing
T48 Protein 256 268 tumor-homing
T49 Biomarker 1405 1413 h-iNSCTE
T50 Condition 959 962 NSC
T51 Protein 733 745 tumor-homing
T52 CL 1673 1687 cytotoxic cell
T53 Level 1608 1613 human
T54 Level 866 871 human
T55 Biomarker 1259 1267 h-iNSCTE
T56 Protein 1517 1521 GBMs
T57 Gene 377 381 gene
T58 Level 639 649 human skin
T59 Protein 1405 1416 h-iNSCTE–TK
T60 Condition 73 85 glioblastoma
T61 Level 1796 1801 human
T62 Level 1608 1618 human skin
T63 Level 208 228 transdifferentiated 
T64 Biomarker 1624 1632 h-iNSCTE
T65 Protein 546 555 Molecular
T66 Level 482 501 patient-derived GBM
